'Ice therapy can treat lung cancer'

Image
Press Trust of India Washington
Last Updated : Apr 15 2013 | 3:30 PM IST
Frozen balls of ice can safely kill cancerous tumours that have spread to the lungs, according to the first prospective multicenter trial of cryoablation.
Cryoablation is a process that uses extreme cold to destroy or damage tissue.
"Cryoablation has potential as a treatment for cancer that has spread to the lungs from other parts of the body and could prolong the lives of patients who are running out of options," said David A Woodrum, author of the study and interventional radiologist at the Mayo Clinic in Rochester.
"We may not be able to cure the cancer, but with cryoablation we can at least slow it down significantly and allow patients to enjoy greater quality of life longer," he added.
Metastatic lung disease is difficult to treat and often signals a poor prognosis for patients.
In the initial results of the study trial, 22 subjects with a total of 36 tumours were treated with 27 cryoablation sessions.
Cryoablation was 100 per cent effective in killing those tumours at three-month follow-up. Follow-up at six months on 5 of the 22 patients (23 per cent) showed the treated tumours to still be dead.
Cryoablation is performed by an interventional radiologist using a small needle-like probe guided through a nick in the skin to cancerous tumors inside the lung under medical imaging guidance.
These tumours have spread - or metastasised - to the lung from primary cancers in other areas of the body. Once in position, the tip of the instrument is cooled with gas to as low as minus 100 degrees Celsius.
The resulting halo of ice crystals can destroy cancer by interrupting its cellular function, protecting nearby healthy, delicate lung tissue. Lung cryoablation has been promising in part due to the low periprocedural morbidity.
"Most of these patients can go home the day after their cryoablation treatment and resume their normal activities," Woodrum said, noting that researchers plan to continue to follow patients for up to five years.
While cryoablation is being developed for the treatment of metastatic lung cancer, the future looks brighter for individuals who once had nowhere else to turn, said Woodrum.
The results were presented at the Society of Interventional Radiology's Scientific Meeting in New Orleans.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 15 2013 | 3:30 PM IST

Next Story